ValuationViz

ARWR fund manager activity

Arrowhead Pharmaceuticals, Inc · Nasdaq. Reported by 4 tracked fund managers in their 13F filings, Q4 2018 to Q2 2026.

Q4 2025

ManagerActivitySharesValue% of portfolioFiled
Ken Fisher - Fisher Asset ManagementAdded1,311,727$87,085,5540.03%Feb 9, 2026
Joel Greenblatt - Gotham Asset ManagementAdded56,273$3,735,9640.01%Feb 17, 2026

Q3 2025

ManagerActivitySharesValue% of portfolioFiled
Ken Fisher - Fisher Asset ManagementAdded1,053,794$36,345,3530.01%Nov 12, 2025
Joel Greenblatt - Gotham Asset ManagementAdded31,863$1,098,9550.00%Nov 14, 2025

Newer quarters · Older quarters